Brief: Volitionrx Announces Proposed Underwritten Public Offering
March 8 (Reuters) - Volitionrx Ltd VNRX.A :
* VOLITIONRX ANNOUNCES PROPOSED UNDERWRITTEN PUBLIC OFFERING
OF
COMMON STOCK
* VOLITIONRX LTD - INTENDS TO USE NET PROCEEDS OF OFFERING
FOR
CONTINUED PRODUCT DEVELOPMENT, CLINICAL STUDIES, PRODUCT
COMMERCIALIZATION
Source text for Eikon: ID:nPnbT9dGMa
Further company coverage: VNRX.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VolitionRX
See all newsBrief: Volitionrx -Files Preliminary Prospectus For 10,006,360 Shares Of Common Stock Offered By Selling Stockholder - SEC Filing
Brief: Volitionrx - Advances Nu.Q Nets Platform Towards Commercialization
Brief: VolitionRX Limited Announces First Quarter 2026 Financial Results
Brief: Volition Reports Breakthrough In Liquid Biopsy Achievement Of Over 99% Purity In Isolating Cancer Dna
Brief: Volition Announces First Ever Automated Nu.Q® Vet Cancer Test With Fujifilm Vet Systems